Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Unknown 4Terminated 2Completed 2Withdrawn 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 4Gastrointestinal 3Breast 2Sarcoma 1Lymphoid 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Breast Neoplasms 1Breast Neoplasm Female 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Diagnostic Imaging × Breast × Clear all
NCT03217539 2018-02-07

WE

Dalarna County Council, Sweden

Phase NA Completed
133,065 enrolled
Breast

Breast Neoplasm Female

NCT01116297 2013-02-18

Tissue Oxygenation Measurements With Modulated Light (S-FLARE)

Beth Israel Deaconess Medical Center

Phase 1 Completed
4 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡